Gastroscopy following a positive fecal occult blood test and negative colonoscopy: Systematic review and guideline

Canadian Journal of Gastroenterology

Volumn 24, Issue 2, 2010, Pages 113-120

  Allard, Johane ^a   Cosby, Roxanne ^b   Del Giudice, M Elisabeth ^c   Irvine, E Jan ^d   Morgan, David ^e   Tinmouth, Jill ^c  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

Colonoscopy; Esophagogastroduodenoscopy; Fecal occult blood test; Mass screening; Systematic review; Upper gastrointestinal cancer

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ANEMIA; CANCER DIAGNOSIS; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIGESTIVE SYSTEM CANCER; DRUG USE; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS CANCER; EVIDENCE BASED PRACTICE; GASTROSCOPY; HEALTH PROGRAM; HUMAN; OCCULT BLOOD TEST; OUTCOME ASSESSMENT; POPULATION; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; UPPER GASTROINTESTINAL TRACT; COLORECTAL TUMOR; DIGESTIVE TRACT ENDOSCOPY; ESOPHAGUS TUMOR; MASS SCREENING; OCCULT BLOOD; STOMACH TUMOR; UTILIZATION REVIEW;

COLONOSCOPY; COLORECTAL NEOPLASMS; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL NEOPLASMS; GASTROSCOPY; HUMANS; MASS SCREENING; OCCULT BLOOD; PRACTICE GUIDELINES AS TOPIC; STOMACH NEOPLASMS;

EID: 77950495251     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/516363     Document Type: Review

References (23)

1. Canadian Cancer Society, National Cancer Institute of Canada. Canadian cancer statistics 2008. Toronto, Canada, Canadian Cancer Society; 2008.
2. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American joint committee on cancer sixth edition staging. J Natl Cancer Inst 2004;96:1420-1425 (Pubitemid 39429665)
3. Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 1994;29:468-473 (Pubitemid 24144518)
4. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-437 (Pubitemid 29128279)
5. Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. Effect of faecal occult blood screening on mortality from colorectal cancer: Results from a randomised controlled trial. Gut 2002;50:840-844 (Pubitemid 34539047)
6. Kronborg O, Jorgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: Results after nine screening rounds. Scand J Gastroenterol 2004;39:846-851 (Pubitemid 39215455)
7. Zappa M, Visioli CB, Ciatto S, et al. Gastric cancer after positive screening faecal occult blood testing and negative assessment. Dig Liver Dis 2007;39:321-326 (Pubitemid 46432240)
8. UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004;329:133.
9. Manfredi S, Piette C, Durand G, Plihon G, Mallard G, Bretagne JF. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance. Endoscopy 2008;40:422-427 (Pubitemid 351696381)
10. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: A population-based analysis. Gastroenterology 2007;132:96-102. (Pubitemid 46108740)
11. Browman GP, Levine MN, Mohide EA, et al. The practice guidelines development cycle: A conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995;13:502-512
12. Chen TH, Yen MF, Lai MS, et al. Evaluation of a selective screening for colorectal carcinoma: The Taiwan Multicenter Cancer Screening (TAMCAS) project. Cancer 1999;86:1116-1128
13. Jouve JL, Remontet L, Dancourt V, et al. Estimation of screening test (Hemoccult) sensitivity in colorectal cancer mass screening. Br J Cancer 2001;84:1477-1481 (Pubitemid 32579339)
14. Thomas WM, Hardcastle JD. Role of upper gastrointestinal investigations in a screening study for colorectal neoplasia. Gut 1990;31:1294-1297
15. Hsia PC, al-Kawas FH. Yield of upper endoscopy in the evaluation of asymptomatic patients with Hemoccult-positive stool after a negative colonoscopy. Am J Gastroenterol 1992;87:1571-1574
16. Chen YK, Gladden DR, Kestenbaum DJ, Collen MJ. Is there a role for upper gastrointestinal endoscopy in the evaluation of patients with occult blood-positive stool and negative colonoscopy? Am J Gastroenterol 1993;88:2026-2029
17. Bini EJ, Rajapaksa RC, Valdes MT, Weinshel EH. Is upper gastrointestinal endoscopy indicated in asymptomatic patients with a positive fecal occult blood test and negative colonoscopy? Am J Med 1999;106:613-618
18. Zuckerman G, Benitez J. A prospective study of bidirectional endoscopy (colonoscopy and upper endoscopy) in the evaluation of patients with occult gastrointestinal bleeding. Am J Gastroenterol 1992;87:62-66
19. Ali M, Yaqub M, Haider Z, Anees I, Bhargava S, Gian J. Yield of dual endoscopy for positive fecal occult blood test. Am J Gastroenterol 2003;98:82-85 (Pubitemid 36135174)
20. Hisamuddin K, Mowat NAG, Phull PS. Endoscopic findings in the upper gastrointestinal tract of faecal occult blood-positive, colonoscopy-negative patients. Dig Liver Dis 2006;38:503-507 (Pubitemid 44356224)
21. Stray N, Weberg R. A prospective study of same day bi-directional endoscopy in the evaluation of patients with occult gastrointestinal bleeding. Scand J Gastroenterol 2006;41:844-850 (Pubitemid 43941245)
22. Silvis SE, Nebel O, Rogers G, Sugawa C, Mandelstam P. Endoscopic complications. Results of the 1974 American society for gastrointestinal endoscopy survey. JAMA 1976;235:928-930
23. Bhatia NL, Collins JM, Nguyen CC, Jaroszewski DE, Vikram HR, Charles JC. Esophageal perforation as a complication of esophagogastroduodenoscopy. J Hosp Med 2008;3:256-262